Trial intelligence / Profile preview

Colonic motility patterns in functional bowel disorders versus healthy controls

2017-002679-25Phase 4Completed

Sponsor
KU Leuven
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of bisacodyl in functional bowel disorder (FBD), irritable bowel syndrome (IBS), chronic constipation and 1 more (2 arms), sponsored by KU Leuven. Started Jul 2017; status: completed.

02

Drugs

bisacodyl
03

Conditions

functional bowel disorder (FBD)irritable bowel syndrome (IBS)chronic constipationChronic diarrhea

Beyond the preview

Go deeper on 2017-002679-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002679-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call